Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruchi Saxena

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2024
Promotion of an Antitumor Immune Program by a Tumor-specific, Complement-activating AntibodyRuchi Saxena, Ryan T Bushey, Michael J Campa, et al.
The International Journal of Biochemistry & Cell Biology|November 12, 2015
Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 functionRuchi Saxena, Garima Gupta, Murli Manohar, et al.
Steroids|July 30, 2013
Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograftRuchi Saxena, Iram Fatima, Vishal Chandra, et al.
Ophthalmology|May 23, 2006
The influence of incision-induced astigmatism and axial lens position on the correction of myopic astigmatism with the Artisan toric phakic intraocular lensMarjolijn C Bartels, Ruchi Saxena, Thomas J T P van den Berg, et al.
Plos One|July 11, 2013
Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 PathwaysRuchi Saxena, Vishal Chandra, Murli Manohar, et al.
BMJ Open|May 4, 2019
Gestational route to healthy birth (GaRBH): protocol for an Indian prospective cohort studyVipin Gupta, Ruchi Saxena, Gagandeep Kaur Walia, et al.
Journal of Cataract and Refractive Surgery|December 10, 2020
Implantation of an iris-fixated phakic intraocular lens for the correction of hyperopia: 15-year follow-upGwyneth A van Rijn, Zoraida S Gaurisankar, Ruchi Saxena, et al.
Molecular and Cellular Endocrinology|March 15, 2017
3-Piperidylethoxypterocarpan: A potential bone anabolic agent that improves bone quality and restores trabecular micro-architecture in ovariectomized osteopenic ratsAshutosh Raghuvanshi, Amit Kumar, Abdul M Tyagi, et al.
Bioorganic & Medicinal Chemistry|August 30, 2011
Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agentsAtul Kumar, Vishwa Deepak Tripathi, Promod Kumar, et al.
Bioorganic & Medicinal Chemistry|July 27, 2019
Corrigendum to "Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents" [Bioorg. Med. Chem. 19 (2011) 5409-5419]Atul Kumar, Vishwa Deepak Tripathi, Promod Kumar, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2024
Promotion of an Antitumor Immune Program by a Tumor-specific, Complement-activating AntibodyRuchi Saxena, Ryan T Bushey, Michael J Campa, et al.
The International Journal of Biochemistry & Cell Biology|November 12, 2015
Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 functionRuchi Saxena, Garima Gupta, Murli Manohar, et al.
Steroids|July 30, 2013
Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograftRuchi Saxena, Iram Fatima, Vishal Chandra, et al.
Ophthalmology|May 23, 2006
The influence of incision-induced astigmatism and axial lens position on the correction of myopic astigmatism with the Artisan toric phakic intraocular lensMarjolijn C Bartels, Ruchi Saxena, Thomas J T P van den Berg, et al.
Plos One|July 11, 2013
Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 PathwaysRuchi Saxena, Vishal Chandra, Murli Manohar, et al.
BMJ Open|May 4, 2019
Gestational route to healthy birth (GaRBH): protocol for an Indian prospective cohort studyVipin Gupta, Ruchi Saxena, Gagandeep Kaur Walia, et al.
Journal of Cataract and Refractive Surgery|December 10, 2020
Implantation of an iris-fixated phakic intraocular lens for the correction of hyperopia: 15-year follow-upGwyneth A van Rijn, Zoraida S Gaurisankar, Ruchi Saxena, et al.
Molecular and Cellular Endocrinology|March 15, 2017
3-Piperidylethoxypterocarpan: A potential bone anabolic agent that improves bone quality and restores trabecular micro-architecture in ovariectomized osteopenic ratsAshutosh Raghuvanshi, Amit Kumar, Abdul M Tyagi, et al.
Bioorganic & Medicinal Chemistry|August 30, 2011
Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agentsAtul Kumar, Vishwa Deepak Tripathi, Promod Kumar, et al.
Bioorganic & Medicinal Chemistry|July 27, 2019
Corrigendum to "Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents" [Bioorg. Med. Chem. 19 (2011) 5409-5419]Atul Kumar, Vishwa Deepak Tripathi, Promod Kumar, et al.
Pageof 5